Innovator of implantable pump technology expands product registration with clinivation’s worldwide Approvals solution.
Natick, MA, November 30, 2007 – clinivation, Inc. announced today that InSet Technologies Incorporated has selected clinivation’s Approvals solution.”InSet is clearly an innovator of next-generation implantable drug pump technology for the treatment of chronic pain and other important diseases and conditions,” said Joseph Kozikowski, M.D., clinivation’s President and Chief Executive Officer. “We are delighted that InSet’s senior management has selected clinivation to help position its products for continued growth and expansion,” he continued.Clinivation’s Approvals Practice delivers regulatory expertise, development strategy, and an outstanding track record.
About InSet Technologies Incorporated
InSet Technologies Incorporated is a medical device company developing proprietary implantable pumps that are designed to deliver therapeutic drugs for the treatment of chronic diseases and conditions.
For more on InSet Technologies, please visit www.insetinc.com.